CRU, accessible via cruint.com, is a dynamic startup that has significantly broadened its scope in recent years. Initially centered on clinical research, CRU has diversified into several key areas including basic academic research, drug development, eHealth technologies, biobanking, patient tourism, private oncology care, diagnostic services in radiology and molecular biology, healthcare infrastructure planning, and educational projects.

CRU primarily serves a diverse clientele comprising academic institutions, healthcare providers, pharmaceutical companies, and research organizations. Operating within the expansive healthcare and biotechnology markets, CRU leverages its expertise to offer a wide array of specialized services.

The company's business model is multifaceted. In clinical research, CRU conducts trials and studies that help bring new drugs and treatments to market. Their biobanking services are particularly innovative, focusing on "just in time" collections that align with active research projects, rather than maintaining large archives of samples. This approach ensures that the samples are relevant and immediately useful, adding significant value to ongoing research efforts.

CRU also generates revenue through its private oncology care services, offering specialized cancer treatments to patients. Additionally, the company is involved in healthcare infrastructure projects, providing planning, development, and investment services to build and improve medical facilities. Their educational initiatives, which include projects, grants, and investments, further contribute to their revenue streams by fostering advancements in medical and scientific knowledge.

In summary, CRU is a versatile and forward-thinking company that integrates various aspects of healthcare and biotechnology to deliver comprehensive services. Their innovative approach to biobanking, combined with their extensive range of services, positions them as a significant player in the healthcare market.

Keywords: Clinical Research, Biobanking, Drug Development, eHealth, Oncology Care, Diagnostic Services, Healthcare Infrastructure, Academic Research, Patient Tourism, Education Projects.